Identification of thiols and glutathione conjugates of depsipeptide FK228 (FR901228), a novel histone protein deacetylase inhibitor, in the blood

被引:28
|
作者
Xiao, JJ
Byrd, J
Marcucci, G
Grever, M
Chan, KK [1 ]
机构
[1] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med & Publ Hlth, Columbus, OH 43210 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
关键词
D O I
10.1002/rcm.976
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Four glutathione (GSH) conjugates and two thiols were detected when depsipeptide FK228, formerly FR901228, a naturally occurring potent histone deacetylase (HDAC) inhibitor, was incubated in rat or human plasma in the presence of GSH. Their structures were elucidated by the high-performance liquid chromatography/electrospray ionization multi-stage mass spectrometry (HPLC/ESI-MSn) technique, and in some cases confirmed by accurate mass measurement. These products were also detected in rat and human blood homogenates following their incubation with FK228, but were not detected in GSH solution alone. A possible scheme for its formation is proposed. One of the thiols has recently been found to be more active as a histone deacetylase inhibitor than the parent compound. Copyright (C) 2003 John Wiley Sons, Ltd.
引用
收藏
页码:757 / 766
页数:10
相关论文
共 50 条
  • [31] Enhanced therapeutic effect on androgen-independent prostate cancer by depsipeptide (FK228), a histone deacetylase inhibitor, in combination with docetaxel
    Zhang, Zhengwang
    Stanfield, Jennifer
    Frenkel, Eugene
    Kabbani, Wareef
    Hsieh, Jer-Tsong
    UROLOGY, 2007, 70 (02) : 396 - 401
  • [32] Multicenter phase II trial of the histone deacetylase inhibitor depsipeptide (FK228) for the treatment of relapsed or refractory multiple myeloma (MM).
    Niesvizky, R
    Ely, S
    Diliberto, M
    Cho, HJ
    Gelbshtein, UY
    Jayabalan, DS
    Aggarwal, S
    Gabrilove, JL
    Pearse, RN
    Pekle, K
    Zafar, F
    Goldberg, Z
    Leonard, JP
    Wright, JJ
    Chen-Kiang, S
    Coleman, M
    BLOOD, 2005, 106 (11) : 724A - 724A
  • [33] The histone deacetylase inhibitor FR901228 perferentially enhances adenovirus transgene expression in bladder cancer
    Okegawa, T
    Horie, S
    Nutahara, K
    Higashihara, E
    Hsieh, JT
    JOURNAL OF UROLOGY, 2003, 169 (04): : 189 - 190
  • [34] The histone deacetylase inhibitor depsipeptide (FR901228) enhances the cytotoxic activity of Ad5-TRAIL against prostate and renal tumor cells
    VanOosten, RL
    Moore, JM
    Griffith, TS
    FASEB JOURNAL, 2004, 18 (04): : A62 - A62
  • [35] Antitumor efficacy of FK228, a novel histone deacetylase inhibitor, depends on the effect on expression of anglogenesis factors
    Sasakawa, Y
    Naoe, Y
    Noto, T
    Inoue, T
    Sasakawa, T
    Matsuo, M
    Manda, T
    Mutoh, S
    BIOCHEMICAL PHARMACOLOGY, 2003, 66 (06) : 897 - 906
  • [36] The histone deacetylase inhibitor depsipeptide (FR901228) enhances the cytotoxic activity of Ad5-TRAIL against human prostate tumor cells
    Griffith, TS
    Moore, J
    Van Oosten, R
    MOLECULAR THERAPY, 2004, 9 : S361 - S362
  • [37] Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer
    Jun Murakami
    Jun-ichi Asaumi
    Noriko Kawai
    Hidetsugu Tsujigiwa
    Yoshinobu Yanagi
    Hitoshi Nagatsuka
    Tetsuyoshi Inoue
    Susumu Kokeguchi
    Shoji Kawasaki
    Masahiro Kuroda
    Noriaki Tanaka
    Nagahide Matsubara
    Kanji Kishi
    Cancer Chemotherapy and Pharmacology, 2005, 56 : 22 - 28
  • [38] Apoptotic cytotoxic effects of a histone deacetylase inhibitor, FK228, on malignant lymphoid cells
    Murata, M
    Towatari, M
    Kosugi, H
    Tanimoto, M
    Ueda, R
    Saito, H
    Naoe, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 2000, 91 (11): : 1154 - 1160
  • [39] Low concentration of a histone deacetylase inhibitor, depsipeptide (FK228), enhances the effect of gemcitabine and docetaxel in hormone refractory prostate cancer cells
    Kanzaki, Masatoshi
    Kakinuma, Hideaki
    Kumazawa, Teruaki
    Inoue, Takamitsu
    Saito, Mitsuru
    Yuasa, Takeshi
    Matsuura, Shinobu
    Satoh, Shigeru
    Tsuchiya, Norihiko
    Habuchi, Tomonori
    JOURNAL OF UROLOGY, 2007, 177 (04): : 50 - 51
  • [40] Combination of histone deacetylase inhibitor depsipeptide (FK228) and ATRA enhances differentiation in ATRA-sensitive and -resistant APL cells.
    Tabe, Y
    Contractor, R
    Konopleva, M
    Igari, J
    Andreeff, M
    BLOOD, 2003, 102 (11) : 258B - 258B